FDA Inspection 1239060 — Nuvisan France SARL
The FDA completed an inspection of Nuvisan France SARL on July 8, 2021 in Biot. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 8, 2021
- Fiscal Year
- 2021
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Biot (France)
Additional Details
Mutual Recognition Agreement (MRA)